The use of anti-CTLA and anti–PD-1 checkpoint blockade therapy 10 days after tumor injections abrogated tumor growth differences in WT and NOS2KO animals (Supplementary Fig. S4E and S4F). The gene discussed is PDCD1; the disease is neoplasm.